Seegene

씨젠 · 096530

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$1.2B (₩1.7T)

Overview

Seegene makes diagnostic reagents, chemical test kits used in laboratories to identify the genetic material of disease-causing pathogens from patient samples, a field known as molecular diagnostics.

Its products are supplied to hospitals and testing institutions worldwide, distributed through local subsidiaries and a network of agents spanning over a hundred countries. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company earns the vast majority of its revenue from exports, with overseas sales accounting for nearly all of its total revenue. Its core technology allows a single test tube to simultaneously detect multiple pathogens, and it holds dozens of proprietary patents covering this approach.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$343.6M
▲ +14.5% YoY
Operating profit · FY2025
US$25M
Turned profitable
Net income · FY2025
US$35.1M
Turned profitable

Revenue

  • FY2023US$266.2M
  • FY2024US$300.2M
  • FY2025US$343.6M

Operating profit

  • FY2023−US$21.8M
  • FY2024−US$11.9M
  • FY2025US$25M

Net income

  • FY2023US$531.3K
  • FY2024−US$14.7M
  • FY2025US$35.1M

Key ratios (FY2025)

ROE
4.8%
Debt/Eq
21.7%
Op. margin
7.3%
Net margin
10.2%
Rev. YoY
▲ +14.5%

Why it matters

Seegene has entered a technology-sharing initiative, including a strategic collaboration with Microsoft to apply artificial intelligence to its reagent-development automation platform.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.